GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » CERo Therapeutics Holdings Inc (NAS:CERO) » Definitions » YoY EPS Growth

CERo Therapeutics Holdings (CERo Therapeutics Holdings) YoY EPS Growth : -11.23% (As of Dec. 2022)


View and export this data going back to 2024. Start your Free Trial

What is CERo Therapeutics Holdings YoY EPS Growth?

YoY EPS Growth is the percentage change of Earnings per Share (Diluted) over the past twelve months. CERo Therapeutics Holdings's YoY EPS Growth for the quarter that ended in Dec. 2022 was -11.23%.

CERo Therapeutics Holdings's Earnings per Share (Diluted) for the six months ended in Dec. 2022 was $-1.15.

CERo Therapeutics Holdings YoY EPS Growth Historical Data

The historical data trend for CERo Therapeutics Holdings's YoY EPS Growth can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

CERo Therapeutics Holdings YoY EPS Growth Chart

CERo Therapeutics Holdings Annual Data
Trend Dec21 Dec22
YoY EPS Growth
- -11.23

CERo Therapeutics Holdings Semi-Annual Data
Dec21 Dec22
YoY EPS Growth - -11.23

CERo Therapeutics Holdings YoY EPS Growth Calculation

YoY EPS Growth is the percentage change of Earnings per Share (Diluted) over the past twelve months.

CERo Therapeutics Holdings's YoY EPS Growth for the fiscal year that ended in Dec. 2022 is calculated as:

YoY EPS Growth (A: Dec. 2022 )
=(Earnings per Share (Diluted) (A: Dec. 2022 )-Earnings per Share (Diluted) (A: Dec. 2021 ))/ | Earnings per Share (Diluted) (A: Dec. 2021 ) |
=(-1.149--1.033)/ | -1.033 |
=-11.23 %

CERo Therapeutics Holdings's YoY EPS Growth for the quarter that ended in Dec. 2022 is calculated as:

YoY EPS Growth (Q: Dec. 2022 )
=(Earnings per Share (Diluted) (Q: Dec. 2022 )-Earnings per Share (Diluted) (Q: Dec. 2021 )) / | Earnings per Share (Diluted) (Q: Dec. 2021 ) |
=(-1.149--1.033)/ | -1.033 |
=-11.23 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

CERo Therapeutics Holdings YoY EPS Growth Related Terms

Thank you for viewing the detailed overview of CERo Therapeutics Holdings's YoY EPS Growth provided by GuruFocus.com. Please click on the following links to see related term pages.

CERo Therapeutics Holdings (CERo Therapeutics Holdings) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » CERo Therapeutics Holdings Inc (NAS:CERO) » Definitions » YoY EPS Growth
Comparable Companies
Traded in Other Exchanges
N/A
Address
201 Haskings Way, Suite 230, San Francisco, CA, USA, 94080
Website
https://www.cero.bio
CERo Therapeutics Holdings Inc is an innovative immunotherapy company advancing the development of next-generation engineered T-cell therapeutics for the treatment of cancer. Its proprietary approach to T cell engineering, which enables it to integrate certain desirable characteristics of both innate and adaptive immunity into a single therapeutic construct, is designed to engage the body's full immune repertoire to achieve optimized cancer therapy.

CERo Therapeutics Holdings (CERo Therapeutics Holdings) Headlines

From GuruFocus

CERo Therapeutics, Inc. Announces Publication of Preclinical Research Supporting the Use of Its Clinical Candidate CER-1236 to Treat AML Patients

By Business Wire • 03-07-2024